Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (121-130 of 328) with videos related to

Pageof 33
Sort By:
Blood Advances|July 18, 2024
Transformation of marginal zone lymphoma to Hodgkin lymphomaKamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapyG J Weiner, S A Kostelny, J R Hillstrom, et al.
Journal of Cancer Survivorship : Research and Practice|January 4, 2020
Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivorsPriyanka A Pophali, Melissa C Larson, Cristine Allmer, et al.
Clinical Epigenetics|January 28, 2023
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myelomaJake Shortt, Peter Galettis, Chan Y Cheah, et al.
Cancer|June 28, 2017
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementationEric M Ammann, Matthew T Drake, Bjarni Haraldsson, et al.
International Journal of Cancer|July 31, 2001
Humanization and characterization of the anti-HLA-DR antibody 1D10S A Kostelny, B K Link, J Y Tso, et al.
Journal of Leukocyte Biology|February 24, 2001
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigensB Jahrsdörfer, G Hartmann, E Racila, et al.
British Journal of Haematology|April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare StudyBrian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Blood|June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1990
Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-lifeA Ulloa-Aguirre, R M Blizzard, E Garcia-Rubi, et al.
Pageof 33

Showing results (121-130 of 328) with videos related to

Sort By:
Pageof 33
Blood Advances|July 18, 2024
Transformation of marginal zone lymphoma to Hodgkin lymphomaKamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapyG J Weiner, S A Kostelny, J R Hillstrom, et al.
Journal of Cancer Survivorship : Research and Practice|January 4, 2020
Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivorsPriyanka A Pophali, Melissa C Larson, Cristine Allmer, et al.
Clinical Epigenetics|January 28, 2023
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myelomaJake Shortt, Peter Galettis, Chan Y Cheah, et al.
Cancer|June 28, 2017
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementationEric M Ammann, Matthew T Drake, Bjarni Haraldsson, et al.
International Journal of Cancer|July 31, 2001
Humanization and characterization of the anti-HLA-DR antibody 1D10S A Kostelny, B K Link, J Y Tso, et al.
Journal of Leukocyte Biology|February 24, 2001
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigensB Jahrsdörfer, G Hartmann, E Racila, et al.
British Journal of Haematology|April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare StudyBrian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Blood|June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1990
Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-lifeA Ulloa-Aguirre, R M Blizzard, E Garcia-Rubi, et al.
Pageof 33